View all adult cancer types
View all pediatric cancer types
Susan F. Smith Center for Women's Cancers
Gynecologic CancerBlood CancersCancer Genetics and PreventionCutaneous (Skin) CancerGastrointestinal CancerGenitourinary CancerHead and Neck CancerHematologyMelanomaNeuro-OncologySarcomaStem Cell TransplantThoracic (Lung) Cancer
Blood DisordersBrain TumorsHematologic MalignanciesSolid TumorsStem Cell Transplant
Dana-Farber Cancer Institute has launched DiscoverCareBelieve.org, a new platform to illustrate what sets Dana-Farber apart — in research discovery... in expert, compassionate care... and in our strong belief in progress for people with cancer everywhere.WebsiteVideoWhat do you #DiscoverCareBelieve?
In its first clinical trial, a breakthrough antibody therapy produced at least partial remissions in a third of patients with multiple myeloma who had exhausted multiple prior treatments, investigators at Dana-Farber Cancer Institute report.
Clinicians at Dana-Farber/Brigham and Women's Cancer Center are now armed with specialized tests to create a precise "tumor profile" for each patient's cancer. Learn about the latest thinking in precision cancer medicine from our researchers and clinicians, and explore a searchable database of clinical trials that focus on targeted therapies by disease, gene, and mutation.
Tari King, MD, has been named Chief of Breast Surgery at Dana-Farber/Brigham and Women's Cancer Center where she will oversee breast surgery and continue to build DF/BWCC's integrated clinical model for treating breast cancer.
Regular consumption of caffeinated coffee may help prevent the return of colon cancer
after treatment and improve the chances of a cure, according to a new, large
study from researchers at Dana-Farber Cancer Institute.
The National Committee for Quality Assurance (NCQA) has recognized four Dana-Farber Community Cancer Care sites in Massachusetts for quality of their patient care services.
Dr. Tracy Balboni wrote an editorial for a study that found doctors and other health care providers discussed religion or spirituality in less than 20 percent of family meetings in the intensive care unit.
Dr. Harold Burstein provided insight to dispel some of the myths about what causes breast cancer.
Dr. Paul Richardson led a study that found an experimental
immune-boosting drug shows promise in fighting the blood cancer multiple
Dr. Elizabeth Buchbinder discussed former president Jimmy Carter’s announcement that he has been diagnosed with melanoma and the latest treatment options available.
Dr. Matthew Davids commented on Boston Red Sox manager
John Farrell’s announcement of being diagnosed with lymphoma.
Dr. Charles Fuchs commented on former president Jimmy Carter’s announcement that he has cancer.
Research by Dr. Christopher Recklitis reported cancer survivors showing few signs of depression are still at significant risk for suicide.
10:00 AM - 11:30 AM
Smith Building, Room 330
In this class you will learn exercises of the mind/body through mindfulness awareness and fluid movement. These techniques will help you to relax, increase concentration, while utilizing the mind, body and spirit to help improve quality of life. This class is open to patients who have been newly diagnosed with cancer, are receiving treatment, or in remission. Family, friends and staff are welcome. Please call the Zakim Center to register at 617-632-3322 or email Zakim_Center@dfci.harvard.edu.
Tai Chi for Optimal Health with Ramel Rones
11:30 AM - 1:00 PM
An Internal Chinese martial art practiced for both defense training and
health benefits. Learn sitting and standing techniques as well as slow moving
meditation. Family, friends and staff are welcome.
For more information or to register, please contact the Zakim Center at
617-632-3322 or Zakim_Center@dfci.harvard.edu.
2:00 PM - 3:00 PM
Connect to your breath, body, and joy through group singing.
Discover how group singing can support relaxation, mood, sense of community,
and pain management. Lyrics will be provided. Song requests and discussion are
welcome, and no prior music experience is required. Family, friends and staff are welcome.
To register please call 617-692-3322 or email: Zakim_Center@dfci.harvard.edu.
Patient referral information, clinical resources and more.
For adults:877-442-3324Quick access: Appointments as soon as the next day for new adult patientsFor children:888-733-4662
Search current cancer clinical trials at Dana-Farber.
There are many ways to support Dana-Farber and the Jimmy Fund.
Top-ranked cancer center in New England for adults (with Brigham and Women's Hospital) — #1 in the nation for children (with Boston Children's Hospital)
Insight features the latest in cancer care and research news from Dana-Farber.Read the blog
Stay current on the latest news by signing up for Spotlight, our email newsletter.View current issueSubscribe now
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: